Detalhe da pesquisa
1.
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche.
Cell
; 185(10): 1694-1708.e19, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447074
2.
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res
; 26(1): 20, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297352
3.
NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
Mod Pathol
; 36(6): 100144, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828363
4.
Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy.
Ann Surg Oncol
; 30(1): 100-106, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941343
5.
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
Cardiovasc Drugs Ther
; 36(3): 547-560, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097193
6.
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Ann Rheum Dis
; 79(2): 225-231, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707357
7.
Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation.
J Immunol
; 198(5): 2028-2037, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122965
8.
Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.
Infect Immun
; 86(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30037791
9.
Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion.
PLoS Pathog
; 10(10): e1004471, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25356793
10.
Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells.
Infect Immun
; 83(6): 2242-54, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25776754
11.
The Risk of Adhesive Bowel Obstruction in Children With Appendicitis: A Systematic Review.
J Pediatr Surg
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565474
12.
Salivary Gland-like Tumors of the Breast.
Arch Pathol Lab Med
; 147(9): 1014-1024, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651394
13.
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Cancer Res
; 83(19): 3284-3304, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450351
14.
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252998
15.
Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
Shock
; 57(1): 95-105, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172614
16.
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.
JCO Precis Oncol
; 6: e2100413, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797509
17.
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.
Expert Opin Ther Targets
; 25(6): 423-433, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34167431
18.
Retinoblastoma protein expression and its predictors in triple-negative breast cancer.
NPJ Breast Cancer
; 6: 19, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32550264
19.
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer.
Clin Breast Cancer
; 20(3): 238-245, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32113750
20.
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 6(10): 1598-1605, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32880602